LPA receptor antagonists (AMC)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameLPA receptor antagonists (AMC)
Drug Alias Namelysophosphatidic acid receptor inhibitors (AMC)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLysophosphatidic acid receptor Edg-2 antagonists
TargetsLysophosphatidic acid receptor Edg-2
Therapy Area/IndicationsPruritusNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAcademic Medical Center University of Amsterdam
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAcademic Medical Center University of Amsterdam
Active IndicationsN/A
Inactive IndicationsPruritusNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A